AD/PD 2019 reception hosted by GCT

Dr. Jeffrey T. Apter at AD/PD 2019GCT hosts evening reception at AD/PD 2019Dr. Jeffrey T. Apter at AD/PD 2019

GCT President, Dr. Jeffrey T. Apter participated in AD/PD 2019, the 14th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders last week in Lisbon.

Following the interactive and ground breaking scientific program, a wonderful evening reception was held by GCT President at Restaurante Tagide for company Friends and Clients. Warm atmosphere, beautiful view and company – everything is just perfect for networking with international medical and scientific professionals in the field of CNS drug development.

Pictured left to right: Dr. Jeffrey T. Apter at AD/PD 2019, GCT evening reception at AD/PD 2019

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.